Details for New Drug Application (NDA): 017391
✉ Email this page to a colleague
NDA 017391 describes IMURAN, which is a drug marketed by Casper Pharma Llc and Sebela Ireland Ltd and is included in two NDAs. It is available from one supplier. Additional details are available on the IMURAN profile page.
The generic ingredient in IMURAN is azathioprine. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the azathioprine profile page.
The generic ingredient in IMURAN is azathioprine. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the azathioprine profile page.
Summary for 017391
| Tradename: | IMURAN |
| Applicant: | Casper Pharma Llc |
| Ingredient: | azathioprine sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
